Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human PKC gamma ELISA Kit (AC2917)
Cat.#: ASET-1506
Specifications
Description Human PKC gamma ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human PKC gamma concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 7.56 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 100-1600 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1367 Porcine Syndecan-1 ELISA Kit (AC2778) Quantitative inquiry ASET-2042 Human Ephrin A4 ELISA Kit (AC3453) Quantitative inquiry ASET-1017 Mouse Iba1 ELISA Kit (AC2428) Quantitative inquiry ASET-2083 Human NCAM2 ELISA Kit (AC3494) Quantitative inquiry ASET-1068 Mouse Wnt10b ELISA Kit (AC2479) Quantitative inquiry ASET-1513 Human APLNR ELISA Kit (AC2924) Quantitative inquiry ASET-2231 Human Dystrophin ELISA Kit (AC3642) Quantitative inquiry ASET-1732 Mouse Eph Receptor A2 ELISA Kit (AC3143) Quantitative inquiry ASET-1114 Rat Copeptin ELISA Kit (AC2525) Quantitative inquiry ASET-1605 Mouse Dystrophin ELISA Kit (AC3016) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket